What we’re doing
The Digital and Interoperable Medicines Programme is making changes to help ensure that information about patient medications, allergies, intolerances and prescriptions can be shared seamlessly between clinical IT systems.
To support this, several changes are being made to dm+d and SNOMED CT UK Drug Extension during 2023 to make these two terminologies more closely aligned in terms of content and availability.
- improve safety and efficiency
- reduce transcription and clinical errors
- allow staff to focus even more on care
- provide patients with a better experience
This is a joint project between NHS Digital, NHS Business Services Authority (NHSBSA) and subject matter experts in dm+d and SNOMED CT UK Drug Extension teams.
A steering group overseeing the project is made up of representatives from:
- Department of Health and Social Care
- NHS England
- NHS Digital
- NHS trusts
- integrated care boards
- Medicines and Healthcare products Regulatory Agency (MHRA)
- NHS Wales
- NHS Scotland
- Health and Social Care Northern Ireland
Engagement has taken place with pharmacy suppliers, Pharmaceutical Services Negotiating Committee (PSNC), Electronic Prescription Service (EPS), trusts, users of pharmacy terminology products and other subject matter experts to agree the delivery approach and to ensure minimum impact on end users, suppliers and users of pharmacy terminology products.
Last edited: 22 December 2022 12:18 pm